INSIGHTS ON CLINICAL TRIAL DESIGN
-
![clinical-development-early-GettyImages-1275317098]( "Medical Insight's Role In Early-Phase Clinical Development")
Medical Insight's Role In Early-Phase Clinical DevelopmentMedical insight reduces risk, strengthens protocols, and accelerates timelines — enhancing safety, feasibility, and collaboration for successful trials and reliable outcomes.
-
![Emvenio clinical research]( "Providing Access To Patients")
Providing Access To PatientsWe believe that delivering meaningful results begins with meeting patients where they are — whether in their homes, within their communities, or in familiar gathering places.
-
![tablet for medicine management, stock research or inventory, Digital technology-GettyImages-1666055403]( "Reducing Inventory Errors In Clinical Trials")
Reducing Inventory Errors In Clinical TrialsCan a digital double-check save your trial from data errors? How does verifying shipments at receipt slash inventory mistakes? Learn to protect protocol integrity and patient safety.
-
![GettyImages-1404912204-lab-sample-analyze-blood-test-tube]( "The Role Of Oncology Biomarkers In Personalizing Hematology Treatment Plans")
The Role Of Oncology Biomarkers In Personalizing Hematology Treatment PlansOncology biomarkers guide personalized treatment and help track disease changes. Learn more about how advancements like liquid biopsies improve precision care.
-
Pioneering Strategies For Early-Phase Oncology Trials2/17/2025
As the field advances, adaptive methodologies and regulatory shifts redefine early-phase oncology trials, promoting efficiency, flexibility, and equitable access.
-
Addressing Trial Design Hurdles Across Alzheimer’s Disease Stages12/10/2025
Explore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.
-
Optimizing Clinical Supply Flexibility With Demand-Led Strategies3/24/2026
Explore demand-led supply strategies for clinical trials. Compare traditional vs. DLS models and learn when pack-to-order, pack-to-stock, or hybrid approaches optimize supply flexibility.
-
Use Data For Fit-For-Purpose Patient Recruitment Strategy10/29/2025
Learn how a proactive, data-integrated approach can transform patient recruitment from a reactive hurdle into a built-in advantage — accelerating enrollment, improving representativeness, and setting studies up for success from day one.
-
Real-World DHT Adherence Insights And Good Practices7/10/2025
While advances in sensors and device design are improving wearability, successful data collection still hinges on participant adherence. The session highlights why addressing this can’t be an afterthought.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1420647055 payments]( "Our Technology")
Built From The Ground Up
Block Clinical understood from the beginning that intuitive technology that integrates openly with other systems and suppliers is the key to a streamlined, affordable solution.
-
![board meeting]( "IRB Review Services For Phase I Research")
With experience overseeing thousands of Phase I studies in the US and Canada, Advarra’s institutional review board (IRB) understands the unique requirements of Phase I study design and conduct. Our dedicated team and processes are built to support your Phase I research needs.
-
![GettyImages-966826582 data, research, analytics]( "Drive Patient Enrollments With Data-Powered Recruitment Engine")
Generate consistent, successful clinical trial recruitment on repeat with Citeline Connect's multifaceted approach to patient engagement and recruitment.
-
![patient-engagement-GettyImages-1758104980]( "Patient Engagement And Retention For Clinical Trials")
Scout delivers patient engagement solutions that keep participants involved in clinical trials while supporting sites, sponsors, and CROs.
With tools that manage payments, travel, and communication, we make it easy for participants to stay connected and confident throughout their trial journey.
-
![Medical data iStock-1210343139]( "Accelerate Clinical Trial Cycle Times With Citeline Study Feasibility")
Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.
